$42.48
−1.53%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$42.84
From 52W high−18.84%
Volume2.24M
Market cap$101.79B
P/E (TTM)77.1x
P/S (TTM)1.8x
Div yield5.70%
Key dataSep 18, 2026
Open
$42.84
From 52W high
−18.84%
Volume
2.24M
Market cap
$101.79B
ValuationView details →
P/E (Fwd)
15.7x
EV/EBITDA
8.6x
P/E (TTM)
77.1x
RSI (14)
39.1
MomentumView details →
1D Return
−1.53%
YTD Return
−12.48%
SummaryUpdated Jun 1, 2026
Sanofi (NASDAQ:SNY) is a multinational pharmaceutical company founded in 1973 and headquartered in Paris, France. Originally known as Sanofi-Aventis until 2011, the company has evolved into one of the world's largest pharmaceutical companies through strategic acquisitions and organic growth. Sanofi operates as a diversified healthcare company with a focus on innovative medicines, vaccines, and consumer health products, serving patients across more than 170 countries worldwide.
Similar companies
Latest newsMore news →
Bavarian Nordic A/S appointed Tarja Stenvall as President and Chief Executive Officer effective October 15, 2026, succeeding Paul Chaplin.3d agoSanofi announced a C$925 million investment in Canada, including C$415 million in partnership funding from the Canadian government and C$55 million from the Ontario provincial government.4d agoSanofi's C$925 million influenza vaccine manufacturing facility in Toronto began production.4d ago